APA

Bailly B., Richard C., Sharma G., Wang L., Johansen L., Cao J., Pendharkar V., Sharma D., Galloux M., Wang Y., Cui R., Zou G., Guillon P., von Itzstein M., Eléouët J. & Altmeyer R. (20180326). Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication. : Scientific reports.

Chicago

Bailly B, Richard C-A, Sharma G, Wang L, Johansen L, Cao J, Pendharkar V, Sharma D-C, Galloux M, Wang Y, Cui R, Zou G, Guillon P, von Itzstein M, Eléouët J-F and Altmeyer R. 20180326. Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication. : Scientific reports.

Harvard

Bailly B., Richard C., Sharma G., Wang L., Johansen L., Cao J., Pendharkar V., Sharma D., Galloux M., Wang Y., Cui R., Zou G., Guillon P., von Itzstein M., Eléouët J. and Altmeyer R. (20180326). Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication. : Scientific reports.

MLA

Bailly B, Richard C-A, Sharma G, Wang L, Johansen L, Cao J, Pendharkar V, Sharma D-C, Galloux M, Wang Y, Cui R, Zou G, Guillon P, von Itzstein M, Eléouët J-F and Altmeyer R. Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication. : Scientific reports. 20180326.